Activators and Inhibitors of NRF2: A Review of Their Potential for Clinical Development
Another potential benefit is that by taking a GLP-1, you might be able to counter the weight-gain-inducing effects of other medications you take for mental health
USD 39.95 Prices may be subject to local taxes which are calculated during checkout Similar content being viewed by others References Sun Y, Wang P, Zheng H, Smith RG
10.1002/jbmr.2564 Summary Keywords glucagonlike peptide1 receptor agonist, randomized controlled trial, older adults, bone mineral density, bone turnover Citation Dinkla L, Beavers KM, Robbins R, Akpalu D, Wherry SJ, Miller G, Beavers DP, Espinoza S, Trejo J, Stepanenko A and Cortes TM (2025) Bone mineral density and turnover response to GLP-1 receptor agonists in older adults with overweight/obesity and prediabetes/type 2 diabetes: a 20-week pilot trial post hoc analysis